BioSpace News Archive

Isofol Medical AB, will publish the company’s year-end report 2021 on Thursday, February 24, 2022.

GC Pharma, a South Korean biopharmaceutical company, announced unaudited consolidated financial results for the year ended 31 December 2021.

Clover announces universal COVID-19 vaccine booster development plan to support global use of its COVID-19 vaccine candidate, SCB-2019 (CpG 1018/Alum).

On Feb. 17, 2022, R. Bryan Riggsbee, chief financial officer, will participate in a fireside chat at the virtual BTIG MedTech, Digital Health, Life Sciences & Diagnostic Tools Conference at 12 p.m. ET.

Merck to Hold Event to Discuss Long-Term Environmental, Social & Governance Priorities.

Duchesnay Inc., a pharmaceutical company specializing in women’s health and part of the Duchesnay Pharmaceutical Group based in Blainville, Quebec, is proud to announce the first treatment launched by its new ownership and management team to help postmenopausal women across Canada who are suffering from vaginal dryness and painful intercourse.

Bio-Techne Corporation (NASDAQ:TECH) today announced an important publication in World Journal of Urology.

Ascensia Diabetes Care has received approval from the U.S. Food and Drug Administration (FDA) for the next-generation Eversense ® E3 Continuous Glucose Monitoring (CGM) System.

Biohaven Pharmaceutical Holding Company Ltd. and Pfizer Inc. (NYSE: PFE), today announced positive top-line results from an Asia-Pacific, Phase 3 clinical trial of rimegepant in 1,431 adults for the acute treatment of migraine.

Castle Biosciences, Inc. today announced that it will release its financial results for the fourth quarter and year-ended Dec. 31, 2021, after the close of market on Monday, Feb. 28, 2022.